BofA/Merrill Lynch Downgrades Bristol-Myers Squibb Co. (BMY) to Neutral
Tweet Send to a FriendGet Alerts BMY Hot Sheet
Price: $43.30 +1.24%
Rating Summary:
6 Buy, 8 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 35 | New: 23
Rating Summary:
6 Buy, 8 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 35 | New: 23
Trade BMY Now!
BofA/Merrill Lynch downgraded Bristol-Myers Squibb Co. (NYSE: BMY) from Buy to Neutral.
For an analyst ratings summary and ratings history on Bristol-Myers Squibb Co. click here. For more ratings news on Bristol-Myers Squibb Co. click here.
Shares of Bristol-Myers Squibb Co. closed at $37.15 yesterday, with a 52 week range of $30.64-$37.25.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For an analyst ratings summary and ratings history on Bristol-Myers Squibb Co. click here. For more ratings news on Bristol-Myers Squibb Co. click here.
Shares of Bristol-Myers Squibb Co. closed at $37.15 yesterday, with a 52 week range of $30.64-$37.25.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Leerink Swann Upgrades Bristol-Myers Squibb Co. (BMY) to Outperform
- Gabelli Sees Fixed Income Sell-Off, Downgrades BlackRock (BLK) to Hold
- Notable 52-Week Highs and Lows of the Day 05/15: (HIMX) (BMY) (SPWR) High; (GGB) (ANV) Low
Create E-mail Alert Related Categories
DowngradesRelated Entities
Merrill Lynch, Bank of America
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
